IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-64919-5.html
   My bibliography  Save this article

Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

Author

Listed:
  • April A. Apfelbaum

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard
    Harvard University)

  • Eric Morin

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard
    Harvard University
    Uppsala University)

  • Dominik Sturm

    (Hopp Children’s Cancer Center Heidelberg (KiTZ)
    a partnership between DKFZ and Heidelberg University Hospital
    German Cancer Research Center (DKFZ)
    Heidelberg University Hospital)

  • Georges Ayoub

    (Dana-Farber Cancer Institute
    Brigham and Women’s Hospital)

  • Jeromy DiGiacomo

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard)

  • Sher Bahadur

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard)

  • Bhavyaa Chandarana

    (Jewish General Hospital
    McGill University)

  • Phoebe C. Power

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Harvard University)

  • Margaret M. Cusick

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center)

  • Dana Novikov

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard)

  • Prem Prabhakar

    (Dana-Farber Cancer Institute)

  • Robert E. Jones

    (Dana-Farber Cancer Institute)

  • Jayne Vogelzang

    (Dana-Farber Cancer Institute)

  • Connor C. Bossi

    (Dana-Farber Cancer Institute)

  • Seth Malinowski

    (Dana-Farber Cancer Institute)

  • Lewis M. Woodward

    (Queen Mary University of London)

  • Tania A. Jones

    (Queen Mary University of London)

  • John Jeang

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard)

  • Sarah W. Lamson

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard)

  • Jared Collins

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard)

  • Kelly Y. Cai

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard)

  • Jacquelyn S. Jones

    (Dana-Farber Cancer Institute)

  • Sehee Oh

    (Dana-Farber Cancer Institute)

  • Hyesung Jeon

    (Dana-Farber Cancer Institute
    Harvard Medical School)

  • Jinhua Wang

    (Dana-Farber Cancer Institute
    Harvard Medical School)

  • Amy Cameron

    (Dana-Farber Cancer Institute)

  • Patrick Rechter

    (Dana-Farber Cancer Institute)

  • Angela Leon

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center)

  • Karthikeyan Murugesan

    (Foundation Medicine Inc)

  • Meagan Montesion

    (Foundation Medicine Inc)

  • Lee A. Albacker

    (Foundation Medicine Inc)

  • Shakti H. Ramkissoon

    (Foundation Medicine Inc
    Labcorp Oncology
    Winston-)

  • Cornelis M. Tilburg

    (a partnership between DKFZ and Heidelberg University Hospital
    Heidelberg University Hospital
    Hopp Children’s Cancer Center Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ))

  • Emily C. Hardin

    (a partnership between DKFZ and Heidelberg University Hospital
    Heidelberg University Hospital
    Hopp Children’s Cancer Center Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ))

  • Philipp Sievers

    (Hopp Children’s Cancer Center Heidelberg (KiTZ)
    University Hospital Heidelberg
    Germany)

  • Felix Sahm

    (German Cancer Research Center (DKFZ)
    Hopp Children’s Cancer Center Heidelberg (KiTZ)
    University Hospital Heidelberg
    Germany)

  • Kee Kiat Yeo

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Harvard University)

  • Tom Rosenberg

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Harvard University)

  • Susan N. Chi

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Harvard University)

  • Karen D. Wright

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Harvard University)

  • Steven Hébert

    (Jewish General Hospital)

  • Sydney Peck

    (Orlando Health- Arnold Palmer Hospital for Children)

  • Alberto Picca

    (Pitié Salpêtrière University Hospital)

  • Valérie Larouche

    (CHU de Québec-Université Laval)

  • Samuele Renzi

    (Chul-Québec)

  • Sara J. Buhrlage

    (Dana-Farber Cancer Institute
    Harvard Medical School)

  • Tejus A. Bale

    (Memorial Sloan Kettering Cancer Center)

  • Amy A. Smith

    (Orlando Health- Arnold Palmer Hospital for Children)

  • Mehdi Touat

    (Pitié Salpêtrière University Hospital)

  • Nada Jabado

    (McGill University)

  • Eric S. Fischer

    (Dana-Farber Cancer Institute
    Harvard Medical School)

  • Michael J. Eck

    (Dana-Farber Cancer Institute
    Harvard Medical School)

  • Lissa Baird

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Harvard University
    Harvard University)

  • Olaf Witt

    (a partnership between DKFZ and Heidelberg University Hospital
    German Cancer Research Center (DKFZ)
    Heidelberg University Hospital
    Hopp Children’s Cancer Center Heidelberg (KiTZ))

  • Claudia L. Kleinman

    (Jewish General Hospital
    McGill University)

  • Quang-De Nguyen

    (Dana-Farber Cancer Institute)

  • Denise Sheer

    (Queen Mary University of London)

  • Sanda Alexandrescu

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Harvard University)

  • David T. W. Jones

    (Hopp Children’s Cancer Center Heidelberg (KiTZ)
    a partnership between DKFZ and Heidelberg University Hospital
    German Cancer Research Center (DKFZ))

  • Keith L. Ligon

    (Broad Institute of MIT and Harvard
    Dana-Farber Cancer Institute
    Brigham and Women’s Hospital
    Harvard University)

  • Pratiti Bandopadhayay

    (Dana-Farber Cancer/Boston Children’s Cancer and Blood Disorders Center
    Broad Institute of MIT and Harvard
    Harvard University)

Abstract

No abstract is available for this item.

Suggested Citation

  • April A. Apfelbaum & Eric Morin & Dominik Sturm & Georges Ayoub & Jeromy DiGiacomo & Sher Bahadur & Bhavyaa Chandarana & Phoebe C. Power & Margaret M. Cusick & Dana Novikov & Prem Prabhakar & Robert E, 2025. "Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas," Nature Communications, Nature, vol. 16(1), pages 1-1, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64919-5
    DOI: 10.1038/s41467-025-64919-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-64919-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-64919-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64919-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.